Nanobiotix S.A.
NBTX
$3.39
$0.24117.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -73.73M | -55.32M | -36.20M | -39.72M | -42.92M |
| Total Depreciation and Amortization | 1.75M | 1.72M | 1.68M | 1.66M | 1.63M |
| Total Amortization of Deferred Charges | 4.40K | 4.40K | 4.40K | 3.30K | 2.20K |
| Total Other Non-Cash Items | 35.37M | 25.69M | 15.57M | 16.35M | 17.08M |
| Change in Net Operating Assets | 15.44M | 16.64M | 17.83M | 14.33M | 10.73M |
| Cash from Operations | -21.16M | -11.26M | -1.11M | -7.37M | -13.47M |
| Capital Expenditure | -915.10K | -727.50K | -534.00K | -446.60K | -354.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -118.00K | -75.00K | -30.40K | -26.70K | -22.80K |
| Cash from Investing | -1.03M | -802.40K | -564.30K | -473.20K | -377.10K |
| Total Debt Issued | -- | 0.00 | 0.00 | 75.00K | 150.00K |
| Total Debt Repaid | -4.16M | -4.04M | -3.93M | -3.85M | -3.77M |
| Issuance of Common Stock | -- | 30.08M | 60.15M | 60.15M | 60.15M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -980.00K | -5.48M | -9.97M | -9.87M | -9.77M |
| Cash from Financing | -5.55M | 22.09M | 50.07M | 50.34M | 50.63M |
| Foreign Exchange rate Adjustments | 101.60K | 56.60K | 10.60K | -22.30K | -55.30K |
| Miscellaneous Cash Flow Adjustments | 1.10K | 1.10K | 1.00K | 500.00 | 0.00 |
| Net Change in Cash | -27.64M | 10.09M | 48.41M | 42.47M | 36.73M |